Shares in the medtech were up 7.9% at 68.5p.
The company said this marked the next stage in establishing US-wide distribution coverage as part of the group’s commercialisation strategy.
1.40pm: Gamma communicates good news
The provider of unified communications as a service (UcaaS) said the business continued to perform well in the first half of the year, with growth in line with the rate associated with expectations for the full year.
The performance of the UK Direct business has been is slightly ahead of our expectations. Growth has been closer to that of previous years despite the lower order intake during the first lockdown period in 2020, Gamma said.
12.45pm: Ebiquity returns to profit
The media monitoring firm said trading in the first half of the year was in line with expectations, with the company seeing a return to profitability.
“We are seeing the results of solid new business performance and developing higher value strategic client relationships. We anticipate further progress in the second half,” said Nick Waters, the Ebiquity CEO.
11.50am: Evgen with double-dose of good news
In the US, it has applied to the Food & Drug Administration for orphan drug (OD) status for SFX-01 in the area of glioma, a brain cancer with a very poor prognosis.
A separate announcement, it said that SFX-01 has shown some very early promise as a potential leukaemia treatment.
10.55am: Castillo Copper surges ahead of publication of exploration results
Castillo Copper Limited (LON:CCZ) has taken over as the morning’s top riser with an 18% rise at 2.425p.
The dual-listed company said trading in its shares have been suspended pending the release of some exploration results.
10.00am: Euro 2020 boost for Smiths News
Smiths News PLC (LON:SNWS) advanced 9.4% to 46.5p after it said trading in the current fiscal year has been ahead of market expectations.
The newspaper and magazines distributor said core sales of newspapers and magazines have continued to stabilise, with positive year-on-year comparators for the months following the anniversary of the first lockdown in March 2020.
The return of major sporting events, particularly the European Football Championship, has further boosted sales of one-shots, stickers and albums, which will generate a one-off benefit of circa GBP1mln to underlying earnings (EBITDA) this financial year (which runs to 28 August).
9.05am: Circassia Group turns a corner; Star Phoenix lines up clean enery venture in Western Australia
The medical device company said the NIOX business was profitable at the EBITDA (underlying earnings) level (excluding corporate costs) for the first time in the first half of 2021.
Unaudited half-year revenues for the NIOX business were about GBP14.5mln, up 27% on the same period last year and up 16% on the second half of 2020.
Star Phoenix Group Ltd (LON:STA), up 18% at 1.65p, was the top riser in London after it said it is evaluating a clean energy play.
The group has signed a non-binding agreement with Curtin University to jointly explore, appraise and develop natural hydrogen (H2) opportunities in Western Australia.
Both parties intend to undertake an initial low-cost work programme over two years from execution of any agreement. The aim would be to appraise natural H2 production points in Western Australia, specifically in areas having a high iron-rich content and circular depressions. Any high priority areas that have the potential to produce large quantities of H2, would then be analysed to determine various parameters for potential future production.